Hannah M Brakke

Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy

R. Hevner, G. Ishak, M. Jensen, 2019, Annals of neurology.

Preemptive Mitigation of CD19 CAR T Cell Cytokine Release Syndrome Without Attenuation of Anti-Leukemic Efficacy.

M. Jensen, A. Taraseviciute, Francesco Ceppi, 2019, Blood.

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.

S. Riddell, K. Kelly-Spratt, A. Oron, 2017, Blood.

CD19 CAR T cell product and disease attributes predict leukemia remission durability.

R. Orentas, M. Jensen, O. Finney, 2019, The Journal of clinical investigation.

Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates.

H. D. Liggitt, S. Furlan, C. Turtle, 2018, Cancer discovery.

Title: Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Non-Human Primates

H. D. Liggitt, S. Furlan, S. Riddell, 2018 .

CD19 CAR T cell product and disease attributes predict leukemia remission durability.

R. Orentas, M. Jensen, O. Finney, 2019, The Journal of clinical investigation.

Starting T Cell and Cell Product Phenotype Are Associated with Durable Remission of Leukemia Following CD19 CAR-T Cell Immunotherapy

R. Orentas, M. Jensen, O. Finney, 2018, Blood.